LeaderPortfolio
Juneja
Ramesh Juneja
Rank #1528
INDIAHealthcarePharmaceuticals

Ramesh Juneja

Net Worth
$2.75B
0% (24h)
Ramesh Juneja is an Indian billionaire businessman best known as the co-founder and chairman of Mankind Pharma, a leading pharmaceutical company in India. His net worth is estimated at $2.9 billion as of 2024. Juneja's career began in 1974 as a medical representative. In 1995, he co-founded Mankind Pharma with his brother Rajeev Juneja, and the company grew to be the fourth-largest pharmaceutical company in India by domestic sales value by 2024..

The Full Dossier

Early Life and Career

Ramesh Juneja was born in Meerut, Uttar Pradesh, India, in 1955. He graduated in science and started his career in the pharmaceutical industry in 1974 as a Medical Representative at KeePharma Ltd.. In this role, he traveled extensively to meet doctors and promote pharmaceutical products. He worked for Lupin Limited for eight years, gaining insights into the pharmaceutical sector.

Rise to Success

In 1995, Ramesh Juneja, along with his brother Rajeev Juneja, co-founded Mankind Pharma. The company started with an initial investment of ₹50 lakhs. Mankind Pharma focused on providing affordable, quality medicines and quickly grew. Key milestones include the successful introduction of brands like Manforce, Prega News, and Unwanted 72. The company's 2023 IPO further solidified its position, with Mankind Pharma becoming the fourth-largest pharmaceutical company in India by domestic sales value in 2024.

Key Business Strategies

Ramesh Juneja's strategies included emphasizing affordable generic medicines to reach a wide audience. He focused on brand recognition and created well-known brands like Manforce. He has also expanded through strategic acquisitions. The company has invested in research and development. Ramesh Juneja has also expanded the company's reach and product portfolio by making astute acquisitions. The company also made popular brands of condoms and pregnancy test kits.

Philanthropy

Ramesh Juneja has also been involved in philanthropic activities through Mankind Pharma's CSR initiatives. The company has contributed to scholarships for underprivileged students and supported educational infrastructure. The company has also contributed to COVID-19 relief efforts.

Career Timeline

2025

Deal Maker Award

Honored with the Deal Maker Award at the BT MindRush event.

2023

Entrepreneur of the Year

Awarded the Entrepreneur of the Year at the Economic Times Awards for Corporate Excellence.

2023

IPO of Mankind Pharma

Mankind Pharma went public.

1995

Co-founded Mankind Pharma

Founded Mankind Pharma with his brother Rajeev Juneja.

1975

First-line manager

Joined Lupin Limited.

1974

Medical Representative

Began his career at KeePharma Ltd.

Philanthropic Impact

Healthcare$6.1 million

COVID-19 Relief

Committed INR 51 crore to support COVID-19 relief, including aid for frontline workers and medical infrastructure.

Healthcare and EducationUndisclosed

JC Juneja Foundation

Funded medical treatments for 40,000 beneficiaries in FY 2023-24, focusing on underserved communities in healthcare and education.

EducationUndisclosed

Project Prosper

Provides scholarships to meritorious students from low-income families in rural areas.

Wealth Trajectory